EGFR mutation status in a series of Turkish non-small cell lung cancer patients

Epidermal growth factor receptor (EGFR) mutations are potential markers driving carcinogenesis, and may alter the response to EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). The frequency of EGFR mutations in patients with NSCLC differs according to sex, smoking...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biomed Rep
Glavni autori: Calibasi-Kocal, Gizem, Amirfallah, Arsalan, Sever, Tolga, Umit Unal, Olcun, Gurel, Duygu, Oztop, Ilhan, Ellidokuz, Hulya, Basbinar, Yasemin
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2020
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7271734/
https://ncbi.nlm.nih.gov/pubmed/32509305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2020.1308
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items